Ge, Y., Zhao, L., Kang, W., Yan, J., Liu, W., Liu, J., Zhou, W. (2025). Neoadjuvant serplulimab with concurrent chemoradiotherapy in resectable esophagogastric junction adenocarcinoma: Phase 2 updated results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2612